TrialThyroid : official journal of the American Thyroid Association2014

Long-term efficacy of modified-release recombinant human thyrotropin augmented radioiodine therapy for benign multinodular goiter: results from a multicenter, international, randomized, placebo-controlled, dose-selection study.

Søren Fast et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.